Pharmaceutical penetration of new drug and pharmaceutical market structure in Taiwan: Hospital-level prescription of thiazolidinediones for diabetes

Yi Wen Tsai, Yu Wen Wen, Weng Foung Huang, Ken N. Kuo, Pei Fen Chen, Hsin Wei Shih, Yue Chune Lee*

*此作品的通信作者

研究成果: Article同行評審

7 引文 斯高帕斯(Scopus)

摘要

This study used Taiwan's National Health Insurance claim database (years 2000-2005) to examine how thiazolidinediones (TZD), a new class of drugs for diabetes, penetrated into Taiwan's hospitals, and its association with the concentration of all diabetes drugs at the hospital level. We collected 72 monthly summaries of diabetes prescriptions from all hospitals in Taiwan. Hospitallevel pharmaceutical concentration was measured by penetration of TZD, defined as monthly market share of TZD in each hospital. Concentration of diabetes drugs was measured by Herfindahl-Hirschman indices. We found a negative association (coefficient = -0.3610) between TZD penetration and concentration of diabetes drug but a positive association between penetration of TZD and the volume of prescribed diabetes drugs (coefficient = 0.4088). In conclusion, hospital characteristics and volume of services determined the concentration of pharmaceuticals at the institution level, reflecting the heterogeneous competition between pharmaceutical companies within each hospital. Institution-level pharmaceutical concentration influences the adoption and penetration of new drugs.

原文English
頁(從 - 到)279-290
頁數12
期刊European Journal of Health Economics
11
發行號3
DOIs
出版狀態Published - 6月 2010

指紋

深入研究「Pharmaceutical penetration of new drug and pharmaceutical market structure in Taiwan: Hospital-level prescription of thiazolidinediones for diabetes」主題。共同形成了獨特的指紋。

引用此